Literature DB >> 20106998

In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.

Rajdeep Choudhury1, Partha Das, Siddhartha Kumar Bhaumik, Tripti De, Tapati Chakraborti.   

Abstract

Proteases have been found to play essential roles in many biological processes, including the pathogenesis of leishmaniasis. Most parasites rely on their intracellular and extracellular protease repertoire to invade and multiply in mammalian host cells. However, few studies have addressed serine proteases in Leishmania and their role in host pathogenesis. Here we report the intracellular distribution of a novel L. donovani secretory serine protease in the flagellar pocket, as determined by immunogold labeling. Flow cytometry and confocal immunofluorescence analysis revealed that the expression of the protease diminishes sequentially from virulent to attenuated strains of this species and is also highly associated with the metacyclic stage of L. donovani promastigotes. The level of internalization of parasites treated with the anti-115-kDa antibody into host macrophages was significantly reduced from that of non-antibody-treated parasites, suggesting that this serine protease probably plays a role in the infection process. In vivo studies confirmed that this serine protease is a potential vaccine candidate. Altogether, the 115-kDa serine protease might play vital roles in L. donovani pathogenesis and hence could be recognized as a potential candidate for drug design.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106998      PMCID: PMC2849349          DOI: 10.1128/CVI.00358-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  33 in total

1.  Expression and cellular localization of molecules of the gp82 family in Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  Vanessa D Atayde; Mauro Cortez; Renata Souza; José Franco da Silveira; Nobuko Yoshida
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

2.  Evaluation of antileishmanial activity of trans-aconitic acid.

Authors:  S Misra; T Sanyal; D Sarkar; P K Bhattacharya; D K Ghosh
Journal:  Biochem Med Metab Biol       Date:  1989-12

3.  Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes.

Authors:  M E Wilson; K K Hardin; J E Donelson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Complete developmental cycle of Leishmania mexicana in axenic culture.

Authors:  P A Bates
Journal:  Parasitology       Date:  1994-01       Impact factor: 3.234

6.  Characterization of an extracellular serine protease of Leishmania (Leishmania) amazonensis.

Authors:  R E Silva-Lopez; M G Pinto Coelho; S G De Simone
Journal:  Parasitology       Date:  2005-07       Impact factor: 3.234

7.  Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.

Authors:  Josie Haydée L Ferreira; Luciana Girotto Gentil; Suzana Souza Dias; Carlos Eduardo C Fedeli; Simone Katz; Clara Lúcia Barbiéri
Journal:  Vaccine       Date:  2007-12-05       Impact factor: 3.641

8.  Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani.

Authors:  Rajdeep Choudhury; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2008-06-29       Impact factor: 3.396

9.  Antigenicity and conformational analysis of the Zn(2+)-binding sites of two Zn(2+)-metalloproteases: Leishmania gp63 and mammalian endopeptidase-24.11.

Authors:  K P Soteriadou; A K Tzinia; E Panou-Pamonis; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; Y Papapoulou; R Matsas
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Delta24(25)-sterol methenyltransferase: intracellular localization and azasterol sensitivity in Leishmania major promastigotes overexpressing the enzyme.

Authors:  Carmen Jiménez-Jiménez; Juana Carrero-Lérida; Marco Sealey-Cardona; Luis Miguel Ruiz Pérez; Julio Alberto Urbina; Dolores González Pacanowska
Journal:  Mol Biochem Parasitol       Date:  2008-04-08       Impact factor: 1.759

View more
  7 in total

1.  Coccinia grandis (L.) Voigt Leaf Extract Exhibits Antileishmanial Effect Through Pro-inflammatory Response: An In Vitro Study.

Authors:  Asmita Pramanik; Dibyendu Paik; Kshudiram Naskar; Tapati Chakraborti
Journal:  Curr Microbiol       Date:  2016-10-31       Impact factor: 2.188

2.  Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds.

Authors:  Virgínia M G Silva; Daniela F Larangeira; Pablo R S Oliveira; Romina B Sampaio; Paula Suzart; Jorge S Nihei; Márcia C A Teixeira; José O Mengel; Washington L C dos-Santos; Lain Pontes-de-Carvalho
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

3.  Leishmania donovani Secretory Mevalonate Kinase Regulates Host Immune Response and Facilitates Phagocytosis.

Authors:  Tanvir Bamra; Taj Shafi; Sushmita Das; Manjay Kumar; Manas Ranjan Dikhit; Ajay Kumar; Ashish Kumar; Kumar Abhishek; Krishna Pandey; Abhik Sen; Pradeep Das
Journal:  Front Cell Infect Microbiol       Date:  2021-04-26       Impact factor: 5.293

4.  Proteinases as virulence factors in Leishmania spp. infection in mammals.

Authors:  Mariana Silva-Almeida; Bernardo Acácio Santini Pereira; Michelle Lopes Ribeiro-Guimarães; Carlos Roberto Alves
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

5.  Development of Leishmania vaccines: predicting the future from past and present experience.

Authors:  Joshua Muli Mutiso; John Chege Macharia; Maria Ndunge Kiio; James Maina Ichagichu; Hitler Rikoi; Michael Muita Gicheru
Journal:  J Biomed Res       Date:  2012-09-30

6.  Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments.

Authors:  José A O'Daly; Humberto M Spinetti; Joe Gleason; María B Rodríguez
Journal:  J Parasitol Res       Date:  2013-06-13

Review 7.  Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.

Authors:  Sumit Joshi; Keerti Rawat; Narendra Kumar Yadav; Vikash Kumar; Mohammad Imran Siddiqi; Anuradha Dube
Journal:  Front Immunol       Date:  2014-08-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.